These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7775644)

  • 21. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?
    Mondaini N; Gontero P; Giubilei G; Lombardi G; Cai T; Gavazzi A; Bartoletti R
    J Sex Med; 2007 Nov; 4(6):1708-12. PubMed ID: 17655657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.
    Amory JK; Watts NB; Easley KA; Sutton PR; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
    J Clin Endocrinol Metab; 2004 Feb; 89(2):503-10. PubMed ID: 14764753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are consecutive nightly recordings required for valid evaluation of sleep-associated erections?
    Greenstein A; Mabjeesh NJ; Sofer M; Kaver I; Matzkin H; Chen J
    Int J Impot Res; 2007; 19(2):196-9. PubMed ID: 16885991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
    Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
    J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers.
    Strauch G; Perles P; Vergult G; Gabriel M; Gibelin B; Cummings S; Malbecq W; Malice MP
    Eur Urol; 1994; 26(3):247-52. PubMed ID: 7805711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a 5 alpha-reductase inhibitor on androgen physiology in the immature male rat.
    George FW; Johnson L; Wilson JD
    Endocrinology; 1989 Nov; 125(5):2434-8. PubMed ID: 2551651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
    Caserini M; Radicioni M; Leuratti C; Terragni E; Iorizzo M; Palmieri R
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):19-27. PubMed ID: 26636418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].
    Jia Y; Cue YG; Wang XD; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS
    Zhonghua Nan Ke Xue; 2005 Jan; 11(1):38-41. PubMed ID: 15704680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen and sleep-related erections.
    Hirshkowitz M; Moore CA; O'Connor S; Bellamy M; Cunningham GR
    J Psychosom Res; 1997 Jun; 42(6):541-6. PubMed ID: 9226601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
    Gur S; Kadowitz PJ; Hellstrom WJ
    Expert Opin Drug Saf; 2013 Jan; 12(1):81-90. PubMed ID: 23173718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone--a double-blind study.
    Brennemann W; Stitz B; Van Ahlen H; Brensing KA; Klingmüller D
    J Androl; 1993; 14(6):407-10. PubMed ID: 8294223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Oral 5-alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in Rat Model.
    Kilic S; Kolukcu E; Erdemir F; Benli I; Arici A
    Urol J; 2019 May; 16(2):205-211. PubMed ID: 30058066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral testosterone in oil: pharmacokinetic effects of 5alpha reduction by finasteride or dutasteride and food intake in men.
    Amory JK; Page ST; Bremner WJ
    J Androl; 2006; 27(1):72-8. PubMed ID: 16400081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of 5 alpha-reductase inhibitors on erectile function.
    Canguven O; Burnett AL
    J Androl; 2008; 29(5):514-23. PubMed ID: 18421068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.
    Moinpour CM; Darke AK; Donaldson GW; Thompson IM; Langley C; Ankerst DP; Patrick DL; Ware JE; Ganz PA; Shumaker SA; Lippman SM; Coltman CA
    J Natl Cancer Inst; 2007 Jul; 99(13):1025-35. PubMed ID: 17596576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.